Patents by Inventor Oliver E. Owen

Oliver E. Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4351899
    Abstract: A test indicator determines concentration, in a biological fluid, of a metabolic acid, such as beta-hydroxybutyrate or lactic acid. The indicator includes a test surface containing the dried residue resulting from impregnation of the surface with components including a tetrazolium salt, nicotinamide adenine dinucleotide (NAD), an electron carrier, and the enzyme that is a dehydrogenase for the specific metabolic acid being assayed. The indicator also includes a physically distinct provision for buffering the reaction. In accordance with the concentration of the metabolic acid being assayed, the indicator provides a predetermined color or intensity which can be observed either with the naked eye or with instrumentation such as a reflectance meter.
    Type: Grant
    Filed: February 19, 1981
    Date of Patent: September 28, 1982
    Inventor: Oliver E. Owen
  • Patent number: 4254222
    Abstract: There is provided a procedure for determining the concentration of a metabolic acid in a biological fluid. The method involves use of a tetrazolium salt, a pyridine nucleotide, an electron carrier, and an enzyme that is a dehydrogenase for the specific acid being assayed. These components are used to form an assay mixture; thereafter a quantity of the fluid to be assayed is combined with the assay mixture, so that there may commence a reaction in which the tetrazolium salt is changed to a formazan in an amount that is indicative of the concentration of the specific acid. In a preferred embodiment, the procedure permits assay of the concentration of beta-hydroxybutyrate, and the assay mixture includes components in the relative proportions of 0.8 micromoles 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride (INT), 0.32 micromoles phenazine methosulfate (PMS), 1.5 micromoles nicotinamide adenine dinucleotide (NAD), and 0.
    Type: Grant
    Filed: July 19, 1978
    Date of Patent: March 3, 1981
    Inventor: Oliver E. Owen